Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond ...

Tiger BioSciences, a leader in regenerative medicine and tissue innovation, today announced the acquisition of Platelet-Rich ...

Alpenglow Biosciences announced a partnership with PathNet to help commercialize use of the startup's 3D microscope ...

On Monday, Microchip said it now expects third-quarter fiscal 2026 net sales of approximately $1.185 billion for the period ...

Rare diseases, defined by FDA as “a disease or condition that affects less than 200,000 people in the United States” (1), may ...

UKRI Innovate UK and NRC IRAP provide funding and advisory support, fostering UK-Canada collaboration in genetic medicine ...

Rather than yeast or microalgae, the company is working with oleaginous bacteria—which it claims are more productive.

Investing.com -- Skye Bioscience Inc (NASDAQ:SKYE) stock jumped 5.3% in premarket trading Monday after the company announced a collaboration with Halozyme Therapeutics (NASDAQ:HALO) to develop a ...

Trading below net cash holdings ahead of that deal, the business faced a challenging outlook. This made it so that I erred on ...

Halozyme Therapeutics (HALO) and Skye Bioscience (SKYE) announced the companies entered into a non-exclusive global collaboration and license ...

The company’s first-in-class and potential best-in-class therapeutics promise to be both effective and organ-protective and ...